Filtered By:
Condition: Heart Attack
Countries: Canada Health
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility?
CONCLUSION: PCI of totally occluded SVG can be performed with a high procedural success rate. However, its clinical utility remains limited by poor follow-up outcomes.PMID:34621494 | PMC:PMC8462047 | DOI:10.4330/wjc.v13.i9.493
Source: World Journal of Cardiology - October 8, 2021 Category: Cardiology Authors: Evan W Nardone Brandon M Madsen Melissa M McCarey David L Fischman Nicholas J Ruggiero Paul Walinsky Alec Vishnevsky Michael P Savage Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility?
CONCLUSION: PCI of totally occluded SVG can be performed with a high procedural success rate. However, its clinical utility remains limited by poor follow-up outcomes.PMID:34621494 | PMC:PMC8462047 | DOI:10.4330/wjc.v13.i9.493
Source: World Journal of Cardiology - October 8, 2021 Category: Cardiology Authors: Evan W Nardone Brandon M Madsen Melissa M McCarey David L Fischman Nicholas J Ruggiero Paul Walinsky Alec Vishnevsky Michael P Savage Source Type: research
